Fiera Capital (Canada)
WST icon

Fiera Capital (Canada)’s West Pharmaceutical WST Stock Holding History

Fiera Capital (Canada)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-140,893
Closed -$46.2M – 484
2024
Q4 		$46.2M Buy
140,893
+16,418
+13% +$5.17M 0.15% 97
2024
Q3 		$37.4M Buy
124,475
+145
+0.1% +$44.4K 0.11% 121
2024
Q2 		$41M Buy
124,330
+4,323
+4% +$1.53M 0.13% 118
2024
Q1 		$47.5M Buy
120,007
+26,129
+28% +$9.67M 0.14% 107
2023
Q4 		$33.1M Buy
93,878
+4,521
+5% +$1.6M 0.1% 122
2023
Q3 		$33.5M Buy
89,357
+5,633
+7% +$2.18M 0.11% 117
2023
Q2 		$32M Sell
83,724
-23,003
-22% -$8.22M 0.09% 121
2023
Q1 		$37M Sell
106,727
-4,537
-4% -$1.33M 0.11% 107
2022
Q4 		$26.2M Sell
111,264
-9,533
-8% -$2.26M 0.08% 126
2022
Q3 		$29.7M Buy
120,797
+7,595
+7% +$2.31M 0.11% 108
2022
Q2 		$34.2M Buy
113,202
+26,440
+30% +$8.6M 0.1% 105
2022
Q1 		$35.6M Buy
86,762
+84,312
+3,441% +$33M 0.09% 128
2021
Q4 		$1.15M Sell
2,450
-300
-11% -$129K ﹤0.01% 404
2021
Q3 		$1.17M Sell
2,750
-250
-8% -$105K ﹤0.01% 359
2021
Q2 		$1.08M Sell
3,000
-700
-19% -$231K ﹤0.01% 403
2021
Q1 		$1.04M Buy
3,700
+300
+9% +$85.9K ﹤0.01% 387
2020
Q4 		$963K Buy
3,400
+170
+5% +$47.7K ﹤0.01% 452
2020
Q3 		$888K Sell
3,230
-270
-8% -$71.5K ﹤0.01% 415
2020
Q2 		$795K Sell
3,500
-200
-5% -$39.3K ﹤0.01% 433
2020
Q1 		$563K Sell
3,700
-1,300
-26% -$200K ﹤0.01% 469
2019
Q4 		$752K Sell
5,000
-1,000
-17% -$146K ﹤0.01% 484
2019
Q3 		$851K Hold
6,000
– – ﹤0.01% 456
2019
Q2 		$751K Sell
6,000
-1,075
-15% -$127K ﹤0.01% 479
2019
Q1 		$780K Buy
7,075
+1,575
+29% +$164K ﹤0.01% 499
2018
Q4 		$539K Buy
5,500
+50
+0.9% +$5.42K ﹤0.01% 518
2018
Q3 		$673K Sell
5,450
-3,275
-38% -$367K ﹤0.01% 524
2018
Q2 		$866K Buy
+8,725
New +$803K ﹤0.01% 490

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fiera Capital (Canada)'s WST Position: Q1 2025 in Review

Fiera Capital (Canada) sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 140,893 shares — an estimated $46.2M sold.

Fiera Capital (Canada) first reported a position in WST in Q2 2018 and held it in 27 quarters. The position peaked at $47.5M in Q1 2024. 714 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Fiera Capital (Canada) reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Fiera Capital (Canada) sold 140,893 West Pharmaceutical shares in Q1 2025, an estimated $46.2M.
  • Fiera Capital (Canada) first reported a position in West Pharmaceutical in Q2 2018 and held it in 27 quarters.
  • Fiera Capital (Canada)'s West Pharmaceutical position peaked at $47.5M in Q1 2024.
  • 714 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2025, filed 7 May 2025.